|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Cancer
:
Pancreatic Cancer
Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half
Consumption of Vitamin D tablets was found to cut the risk of pancreatic cancer nearly in half, according to a study led by researchers at Northwestern and Harvard universities. The findings point to Vitamin D�s potential to prevent the disease, and is one of the first known studies to use a large-scale epidemiological survey to examine the relationship between the nutrient and cancer of the pancreas. The study, led by Halcyon Skinner, Ph.D., of Northwestern, appears in the September issue of Cancer Epidemiology Biomarkers & Prevention.
Sep 13, 2006, 12:00
Latest Research
:
Cancer
:
Pancreatic Cancer
Post operative gemcitabine combination therapy improves survival in pancreatic cancer
Adding the cancer-fighting drug gemcitabine to standard therapy after surgery significantly improves survival for patients with the most common form of pancreatic cancer, according to a new multicenter study led by a University of Maryland radiation oncologist.
Jun 5, 2006, 16:41
Latest Research
:
Cancer
:
Pancreatic Cancer
Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice
A gene responsible for the production of a protein called vasostatin may prove a promising new way of treating pancreatic cancer, suggests research published ahead of print in Gut.
Nov 15, 2005, 15:10
Latest Research
:
Cancer
:
Pancreatic Cancer
FDA Approves Tarceva for Advanced Pancreatic Cancer
Tarceva (erlotinib), the only EGFR-inhibitor to have shown a survival benefit in lung cancer, will now benefit patients with advanced pancreatic cancer following FDA approval in the United States. Pancreatic cancer is one of the most aggressive forms of the disease and kills more people within the first year than any other cancer. Tarceva is the first new treatment in a decade that has shown a significant improvement in overall survival (23%) when added to chemotherapy.
Nov 8, 2005, 16:29
Latest Research
:
Cancer
:
Pancreatic Cancer
Xeloda Dramatically Extends Survival Rates in Pancreatic Cancer
The interim analysis of one of the largest phase III studies investigating the first-line treatment of advanced pancreatic cancer shows that adding Xeloda(R) (capecitabine) to standard chemotherapy (gemcitabine) significantly extends patient survival.
Nov 8, 2005, 15:28
Latest Research
:
Cancer
:
Pancreatic Cancer
Red Meat Associated With Pancreatic Cancer Risk
High consumption of red and processed meats--but not fat or cholesterol--is associated with an increased risk of pancreatic cancer, according to a new study.
Oct 5, 2005, 04:39
Latest Research
:
Cancer
:
Pancreatic Cancer
3D MRI Useful in Detecting Most Lethal Cancers
3D MRI can detect pancreatic cancer when it is smaller and patients have a greater likelihood of survival, a new study shows.
Sep 7, 2005, 07:47
Latest Research
:
Cancer
:
Pancreatic Cancer
New onset of hyperglycemic diabetes in adults age 50 or older - signal of underlying pancreatic cancer
In a groundbreaking population-based study, researchers in Mayo Clinic Cancer Center found that new onset of hyperglycemic diabetes in adults age 50 or older may be a signal of underlying pancreatic cancer. The risk of developing the cancer within three years after a new diagnosis of diabetes is eight times higher than for the average same-age individual.
Aug 1, 2005, 17:00
Latest Research
:
Cancer
:
Pancreatic Cancer
Protein responsible for unchecked cell growth found
Making new strides in their ongoing effort to understand mechanisms behind the relentless growth of cancer cells, researchers at Dartmouth Medical School have found a promising key that may open doors to future treatments in pancreatic and other forms of cancer. The innovation lies in manipulating an overabundance of chemo-resistant molecules in pancreatic cancer that inactivate pathways that would normally suppress cell growth.
Jun 12, 2005, 05:48
Latest Research
:
Cancer
:
Pancreatic Cancer
Disease progression model of pancreatic cancer developed
Building on previous work, researchers at the University of Pennsylvania School of Medicine have developed an animal model of pancreatic cancer that closely mimics disease progression in humans. From this, they hope to develop new treatments for this deadly disease. Advanced pancreatic cancer is among the most lethal of cancers, with a one-year survival rate after chemotherapy of only 17 to 28 percent of patients, according to the National Cancer Institute.
May 21, 2005, 00:03
Latest Research
:
Cancer
:
Pancreatic Cancer
Processed Meats Linked to Pancreatic Cancer
Heavy consumption of hot dogs, sausages and luncheon meats, along with other forms of processed meat, was associated with the greatest risk of pancreatic cancer in a large multiethnic study reported today at the 96th Annual Meeting of the American Association for Cancer Research.
Apr 21, 2005, 17:49
Latest Research
:
Cancer
:
Pancreatic Cancer
No Association Between Dietary Patterns and Pancreatic Cancer
Researchers from the Harvard School of Public Health (HSPH), assessing dietary patterns among men and women and risk of pancreatic cancer, found no association with two wide-ranging dietary patterns and the risk of pancreatic cancer.
Apr 6, 2005, 17:08
|
